Management tracks

Oncology company Affimed N.V. (NASDAQ:AFMD) named Joerg Windisch COO. Windisch was CSO at the Sandoz unit of Novartis AG (NYSE:NVS; SIX:NOVN).

Emergent BioSolutions Inc. (NYSE:EBS) named a management team for planned oncology and hematology spinout Aptevo Therapeutics Inc. Emergent director Martin White will be Aptevo's CEO. Jeff Lamothe will be SVP and CFO, and Scott Stromatt will be CMO and SVP of clinical development and medical affairs. Lamonthe is VP of finance at Emergent's Biosciences division, and Stromatt is Emergent's CMO. ...